コンテンツへスキップ
Merck
  • Influence of collagen and chondroitin sulfate (CS) coatings on poly-(lactide-co-glycolide) (PLGA) on MG 63 osteoblast-like cells.

Influence of collagen and chondroitin sulfate (CS) coatings on poly-(lactide-co-glycolide) (PLGA) on MG 63 osteoblast-like cells.

Physiological research (2011-08-05)
M Vandrovcová, T Douglas, D Hauk, B Grössner-Schreiber, J Wiltfang, L Bačáková, P H Warnke
要旨

Poly-(lactide-co-glycolide) (PLGA) is an FDA-approved biodegradable polymer which has been widely used as a scaffold for tissue engineering applications. Collagen has been used as a coating material for bone contact materials, but relatively little interest has focused on biomimetic coating of PLGA with extracellular matrix components such as collagen and the glycosaminoglycan chondroitin sulfate (CS). In this study, PLGA films were coated with collagen type I or collagen I with CS (collagen I/CS) to investigate the effect of CS on the behaviour of the osteoblastic cell line MG 63. Collagen I/CS coatings promoted a significant increase in cell number after 3 days (in comparison to PLGA) and after 7 days (in comparison to PLGA and collagen-coated PLGA). No influence of collagen I or collagen I/CS coatings on the spreading area after 1 day of culture was observed. However, the cells on collagen I/CS formed numerous filopodia and displayed well developed vinculin-containing focal adhesion plaques. Moreover, these cells contained a significantly higher concentration of osteocalcin, measured per mg of protein, than the cells on the pure collagen coating. Thus, it can be concluded that collagen I/CS coatings promote MG 63 cell proliferation, improve cell adhesion and enhance osteogenic cell differentiation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクロナール抗β-アクチン マウス宿主抗体, clone AC-15, ascites fluid
Sigma-Aldrich
モノクローナル抗ビンキュリン抗体 マウス宿主抗体, clone hVIN-1, ascites fluid
Sigma-Aldrich
抗ウサギIgG (全分子)-ペルオキシダーゼ ヤギ宿主抗体, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
抗マウスIgG (Fab特異的)-ペルオキシダーゼ ヤギ宿主抗体, affinity isolated antibody, buffered aqueous solution